The effects of administration of theLactobacillus gasseristrain CP2305 on quality of life, clinical symptoms and changes in gene expression in patients with irritable bowel syndrome
2016 ◽
Vol 122
(1)
◽
pp. 212-224
◽
Keyword(s):
2018 ◽
Vol 38
(4)
◽
pp. 327-333
◽
Keyword(s):
2017 ◽
Vol 62
(6)
◽
pp. 1550-1560
◽
2020 ◽
Vol 54
(5)
◽
pp. e40-e49
Keyword(s):
2001 ◽
Vol 120
(5)
◽
pp. A634-A634
◽
2021 ◽
Vol 14
◽
pp. 175628482199358